Bio Korea in May 2025

 

WHAT 

The Korean life science industry has opened diverse opportunities across various sectors, including pharmaceuticals, biotechnology, and CDMO. The synergy between Sweden’s innovative pharmaceutical sector and South Korea’s growing, evolving market—supported by a favourable business environment—makes it a key destination for Swedish companies seeking new opportunities. 

Here are key opportunities for Swedish companies: 

Clinical Trials 

  • Swedish pharmaceutical and biotech companies can take advantage of Korea's efficient regulatory environment and strong clinical trial infrastructure to conduct clinical trials. Korea's proven track record in successful clinical research can accelerate the development and approval of new drugs. 

Biopharmaceutical Manufacturing (CDMO) 

  • Swedish companies can collaborate with leading Korean biopharmaceutical manufacturers like Samsung Biologics and Celltrion. Outsourcing production or forming joint ventures can enhance manufacturing capabilities and meet global demand. 

Technology Transfer 

  • There is potential for technology transfer in areas such as precision medicine, regenerative medicine, and gene therapy. Swedish innovations can be brought to the Korean market through licensing agreements or technology partnerships. 

Health Tech and Digital Health 

  • With both countries showing strong capabilities in digital technologies, there is significant potential for collaboration in health tech, including telemedicine, digital diagnostics, and health data analytics. 

 

By capitalizing on these opportunities, Swedish companies can not only expand their presence in Asia but also contribute to and benefit from the dynamic and innovative Korean life science industry. 
 

HOW 

Connect and develop an international network in one of the fastest-growing life science markets in the world. In collaboration with the Embassy of Sweden in Seoul and Korean life science industry associations, Business Sweden aims to strengthen cooperation between Sweden and South Korea. 

At Bio Korea 2025, Swedish delegates will showcase their innovative life science pipelines and technologies, fostering business collaborations between the two nations. The overarching goal of the event is to promote Sweden's innovative life science industry to Korean stakeholders and create an environment that accelerates business collaboration between the two countries. 

Place: COEX, Seoul, South Korea 

Date: 6-9 May 2025 

 

CONTACT US 

For more information contact Yooran Lee at Yooran.Lee@business-sweden.se